These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2171176)

  • 21. Comparative evaluation of cell culture-adapted and chicken embryo-adapted fowl pox vaccine strains.
    Baxi MK; Oberoi MS
    Avian Dis; 1999; 43(1):16-21. PubMed ID: 10216755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine.
    Swayne DE; Beck JR; Kinney N
    Avian Dis; 2000; 44(1):132-7. PubMed ID: 10737653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a commercial modified live virus fowl pox vaccine for the control of "variant" fowl poxvirus infections.
    Fatunmbi OO; Reed WM
    Avian Dis; 1996; 40(3):582-7. PubMed ID: 8883788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psittacine pox virus: virus isolation and identification, transmission, and cross-challenge studies in parrots and chickens.
    Boosinger TR; Winterfield RW; Feldman DS; Dhillon AS
    Avian Dis; 1982; 26(2):437-44. PubMed ID: 6285884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunogenic properties of lyophilized vaccine against fowl pox produced on a New Jersey strain of pigeon].
    Peneva-Todorova R; Andreev S; Dilovski M
    Vet Med Nauki; 1982; 19(10):32-6. PubMed ID: 6304992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Peroral immunization against pox. 5. Effectiveness of drinking water vaccination against fowl pox].
    Danner K; Herlyn M; Gerbermann H; Mayr A
    Zentralbl Veterinarmed B; 1975 Jun; 22(4):274-84. PubMed ID: 169653
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of a recombinant fowl pox-based Newcastle disease virus vaccine candidate against velogenic and respiratory challenge.
    Taylor J; Christensen L; Gettig R; Goebel J; Bouquet JF; Mickle TR; Paoletti E
    Avian Dis; 1996; 40(1):173-80. PubMed ID: 8713031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Values of Fowlpox ELISA and the Presence of "Takes" After Vaccination.
    Barreda CB
    Avian Dis; 2016 Mar; 60(1):67-9. PubMed ID: 26953946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In ovo vaccination of specific-pathogen-free chickens with vaccines containing multiple agents.
    Gagic M; St Hill CA; Sharma JM
    Avian Dis; 1999; 43(2):293-301. PubMed ID: 10396643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safe and effective use of fowlpox virus as a vector for poultry vaccines.
    McMillen JK; Cochran MD; Junker DE; Reddy DN; Valencia DM
    Dev Biol Stand; 1994; 82():137-45. PubMed ID: 7958468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to Newcastle disease virus vaccine, fowl-pox vaccine, and Escherichia coli vaccine in Bedouin and White Leghorn chickens.
    Heller D; Soller M; Peleg BA; Ron-Kuper N; Hornstein K
    Poult Sci; 1981 Jan; 60(1):34-7. PubMed ID: 6262741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of route of administration on the efficacy of a recombinant fowlpox virus against H5N2 avian influenza.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1992; 36(4):1052-5. PubMed ID: 1336657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparative trials of the effectiveness of 3 fowl pox vaccines using a standardized challenge infection].
    Tittes-Rittershaus V; Raddei J; Danco A; Rüger R; Fritzsche K
    Zentralbl Veterinarmed B; 1979 Oct; 26(8):668-78. PubMed ID: 230667
    [No Abstract]   [Full Text] [Related]  

  • 34. Vaccination of chickens with a recombinant fowlpox virus containing the hemagglutinin-neuraminidase gene of Newcastle disease virus under the control of the fowlpox virus thymidine kinase promoter.
    Nagy E; Krell PJ; Heckert RA; Derbyshire JB
    Can J Vet Res; 1994 Oct; 58(4):306-8. PubMed ID: 7889464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccinating chickens against avian influenza with fowlpox recombinants expressing the H7 haemagglutinin.
    Boyle DB; Selleck P; Heine HG
    Aust Vet J; 2000 Jan; 78(1):44-8. PubMed ID: 10736685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The addition of fowlpox and pigeon pox vaccine to Marek's vaccine for broilers.
    Siccardi FJ
    Avian Dis; 1975; 19(2):362-5. PubMed ID: 168854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses.
    Karaca K; Sharma JM; Winslow BJ; Junker DE; Reddy S; Cochran M; McMillen J
    Vaccine; 1998 Oct; 16(16):1496-503. PubMed ID: 9711795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total haemolytic complement profile in chicks following fowl pox vaccination or infection.
    Kapil S; Das SK; Kumar A
    Acta Virol; 1989 Jan; 33(1):87-90. PubMed ID: 2565680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses.
    Beard CW; Schnitzlein WM; Tripathy DN
    Avian Dis; 1991; 35(2):356-9. PubMed ID: 1649592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Canary pox vaccination with live embryo-attenuated virus.
    Hitchner SB
    Avian Dis; 1981; 25(4):874-81. PubMed ID: 6279074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.